Salarius Pharmaceuticals

About:

Salarius Pharmaceuticals is an oncology-based biotechnology company developing new therapies to address gene dysregulation.

Website: http://www.salariuspharma.com

Twitter/X: SalariusPharma

Top Investors: Keiretsu Capital, Cancer Prevention and Research Institute of Texas, Tech Coast Angels

Description:

Salarius Pharmaceuticals is an emerging biotechnology company developing targeted therapies to treat pediatric and other cancers, including advanced solid tumors. The lead compound Seclidemstat represents a potential paradigm shift in the treatment of cancer and we are initially targeting Ewing sarcoma, a devastating pediatric, adolescent and young adult bone cancer where no targeted therapies are currently available.